Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics, US Genomics to Develop miRNA-Based Test for Lung Cancer

NEW YORK, May 24 (GenomeWeb News) - Rosetta Genomics and US Genomics today said that they will co-develop an microRNA-based, non-invasive early-detection test for lung cancer.

 

The collaboration will pair US Genomics' Trilogy 2020 platform and Direct miRNA assay with Rosetta Genomics' microRNAs to create a molecular diagnostic that uses a blood sample to identify lung cancer, according to the firms.

Financial details were not discussed.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.